VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC 深 滬
等待開盤 10-03 09:30:00 美东时间
66.4437
-0.285
-0.43%
華盛通- 最 高66.7331
- 今 開66.7331
- 成交量 7951股
- 最 低 66.375
- 昨 收 66.7291
- 總市值 7.64亿
- 52周最高 66.8444
- 市盈率 靜 --
- 換手率 0.07%
- 52周最低 56.2626
- 委 比 0.00%
- 總股本 1149.93万
- 歷史最高 66.918
- 量 比 0.35
- 振 幅 0.54%
- 歷史最低 14.8372
- 每 手 1
- 風險率 1.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多腾势N8L,比亚迪旗下高端新能源品牌的最新力作
（来源：车联新生态） 腾势N8L作为比亚迪旗下高端新能源品牌的最新力作，自开启预售以来便引发市场高度关注。这款定位于中大型插电混动六座SUV的车型，以31.9...
今天 00:00
Vivos' Study Demonstrates Its Daytime-Nighttime Appliance Provides Relief, Quality Of Life Improvement In Children With Attention-Deficit/Hyperactivity Disorder, Obstructive Sleep Apnea
Previously Unpublished Data Confirms Vivos DNA Devices Offer a Safe and Effective Alternative Treatment for Children with ADHD and Obstructive Sleep Apnea LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos
09-30 20:41
最后一天！美政府各部门陆续发布停摆计划 数十万雇员或被迫休假
①截至当地时间周一下午，至少已有八个美国内阁部门制定了详细的停摆计划； ②这些部门占到联邦政府员工总数的三分之二以上，这些方案将合计要求超过40万名非必要员工停职休假。
09-30 13:50
CDC权威推荐成催化剂 大摩：看好吉利德(GILD.US)HIV新药市场前景 重申“买入”评级
摩根士丹利分析师Terence Flynn发表研报，重申吉利德科学“买入”评级，并将目标价定为143美元。
09-29 14:55
Moderna opens manufacturing and R&D facility in the UK
Moderna (NASDAQ:MRNA) said on Wednesday that the Moderna Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK, has officially opened. The MITC will ...
09-25 12:44
公共卫生风险加剧！美国犹他州和亚利桑那州再度爆发麻疹疫情
①美国麻疹感染病例今年已累计达1514例，41个州均出现麻疹确诊病例，创下自1992年以来的新高； ②在得州8月宣布本轮地方流行结束后，犹他州与亚利桑那州交界区域又出现了新的传播链。
09-25 00:41
Sanofi ordered to pay over $177M in France over anticompetitive behavior
An appeals court in France on Wednesday ordered Sanofi (NASDAQ:SNY) and its Winthrop Industrie subsidiary to pay €150.7M ($177.1M) to the country’s National Health Insurance Fund (CNAM) over its alleg...
09-24 22:27
Infratil’s CDC Secures Major Data Center Contracts
Infratil Limited ( ($IFUUF) ) has provided an announcement. Infratil Limited an...
09-24 12:37
Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows
Moderna's 2025-2026 mNEXSPIKE showed strong immune response and safety in Phase 4 trials, reinforcing FDA approval for the LP.8.1-targeting formula.
09-24 00:06
Pfizer nears $7.3B takeover of weight loss drugmaker Metsera, FT reports
Pfizer (NYSE:PFE) is closing in on a potential $7.3 billion takeover of weight-loss drug maker (NASDAQ:MTSR) Metsera, the Financial Times reported on Sunday. The U.S. pharma giant looks to buy New Y...
09-22 13:45
